Case of Generalized Granuloma Annulare Treated with Low Dose Naltrexone + PUVA

Main Article Content

Taylor Gladys
Taehan Kim
Colleen J Beatty
Sonal Choudhary

Keywords

granuloma annulare, photodynamic therapy, treatment, granulomatous disease, case report

Abstract

Granuloma annulare (GA) is a common, noninfectious granulomatous skin condition that usually presents in its localized form, characterized by flesh-colored to erythematous papules coalescing into annular plaques without scale, commonly on the dorsal hands. Lesions can be pruritic and often resolve without treatment in two years. However, the generalized form of GA has a lower incidence and presents with similar morphology, but with >10 lesions in a widespread distribution. Generalized GA is known to be more symptomatic, longer-lasting, and recalcitrant to treatment. The diagnosis is made based on clinicopathological correlation with palisading granulomas around degenerated collagen in the dermis, mucin, and infiltrative lymphocytes and histiocytes. Treatment remains challenging as evidence is limited to case reports, case series, and a few retrospective studies. Here we present the case of a 59-year-old Caucasian female with pruritic rash that began on her abdomen and spread to her extremities over two months. Biopsy revealed superficial histiocytic infiltrates palisading around eosinophilic areas of altered collagen, multiple multinucleate giant cells with elastophagocytosis and lymphohistiocytic perivascular infiltrates, and mucin in the dermis on colloidal iron staining. Overall, this was consistent with generalized GA. The patient was started on a combination of low dose naltrexone (LDN) and psoralen and ultraviolet A (PUVA) therapy. At a five-month follow up visit, she demonstrated near complete resolution of symptoms without any serious adverse effects.

References

1. Thornsberry LA, English JC 3rd. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013 Aug;14(4):279-90. doi: 10.1007/s40257-013-0029-5. PMID: 23696233.

2. Nordmann TM, Kim JR, Dummer R, Anzengruber F. A monocentric, retrospective analysis of 61 patients with generalized granuloma annulare. Dermatology. 2020 May; 236(4): 369-74. Doi: 10.1159/000507247. PMID: 32403113.

3. Cunningham L, Kirby B, Lally A, Collins P. The efficacy of PUVA and narrowband UVB phototherapy in the management of generalized granuloma annulare. J Dermatolog Treat. 2016 Mar; 27(2): 136-39. Doi: 10.3109/09546634.2015.1087461

4. Toljan K, Vrooman B. Low-Dose Naltrexone (LDN) – Review of Therapeutic Utilization. Med Sci (Basel). 2018 Dec; 6(4): 82. Doi: 10.3390/medsci6040082. PMID: 30248938

5. Jaros J, Lio P. Low Dose Naltrexone in Dermatology. J Drugs Dermatol. 2019 Mar; 18(3):235-238. PMID: 30909326.

6. Ekelem C, Juhasz M, Khera P, Mesinkovska NA. Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions. JAMA Dermatol. 2019 Feb; 155(2):229-236. Doi: 10.1001/jamadermatol.2018.4093

7. Browne F, Turner D, Goulden V. Psoralen and ultraviolet A in the treatment of granuloma annulare. 2011 Apr; 27(2): 81-84. Doi: 10.1111/j.1600-0781.2011.00574.x

8. Rathod DG, Muneer H, Masood S. Phototherapy. 2021 Jul 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan; PMID: 33085287.

Similar Articles

You may also start an advanced similarity search for this article.